TI
ORIC icon

Trexquant Investment’s Oric Pharmaceuticals ORIC Stock Holding History

Trexquant Investment’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4M Buy
221,819
+197,847
+825% +$1.79M 0.01% 1118
2026
Q1 		$304K Buy
+23,972
New +$272K ﹤0.01% 1593
2025
Q2 		– Sell
-76,093
Closed -$425K – 1782
2025
Q1 		$425K Buy
+76,093
New +$665K ﹤0.01% 1323
2024
Q4 		– Sell
-25,220
Closed -$259K – 1779
2024
Q3 		$259K Buy
+25,220
New +$249K ﹤0.01% 1387
2023
Q3 		– Sell
-19,981
Closed -$155K – 1721
2023
Q2 		$155K Buy
+19,981
New +$113K ﹤0.01% 1345
2022
Q2 		– Sell
-53,760
Closed -$287K – 1763
2022
Q1 		$287K Buy
+53,760
New +$484K 0.01% 1029

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trexquant Investment's ORIC Position: Q2 2026 in Review

Trexquant Investment increased its Oric Pharmaceuticals (ORIC) stake by 825% in Q2 2026, buying an estimated $1.79M and bringing the position to 221,819 shares worth $2.4M. The position accounts for 0.01% of the portfolio, ranked #1118.

Trexquant Investment first reported a position in ORIC in Q1 2022 and has held it in 6 quarters since. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Trexquant Investment held 221,819 shares of Oric Pharmaceuticals worth $2.4M as of Q2 2026.
  • Trexquant Investment bought 197,847 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.79M.
  • Oric Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1118 holding.
  • Trexquant Investment first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 6 quarters since.
  • 181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.